AAAAAA

   
Results: 1-18 |
Results: 18
RAPID HEMATOPOIETIC RECOVERY AFTER MULTICYCLE HIGH-DOSE CHEMOTHERAPY - ENHANCEMENT OF FILGRASTIM-INDUCED PROGENITOR-CELL MOBILIZATION BY RECOMBINANT HUMAN STEM-CELL FACTOR
Authors: BASSER RL TO LB BEGLEY CG MAHER D JUTTNER C CEBON J MANSFIELD R OLVER I DUGGAN G SZER J COLLINS J SCHWARTZ B MARTY J MENCHACA D SHERIDAN WP FOX RM GREEN MD
Citation: Rl. Basser et al., RAPID HEMATOPOIETIC RECOVERY AFTER MULTICYCLE HIGH-DOSE CHEMOTHERAPY - ENHANCEMENT OF FILGRASTIM-INDUCED PROGENITOR-CELL MOBILIZATION BY RECOMBINANT HUMAN STEM-CELL FACTOR, Journal of clinical oncology, 16(5), 1998, pp. 1899-1908
SELECTED AUTOLOGOUS PERIPHERAL-BLOOD CD34-1+ LIN- HEMATOPOIETIC STEM-CELL (HSC) TRANSPLANTATION IN MULTIPLE-MYELOMA (MM)( THY)
Authors: ARCHIMBAUD E PHILIP I COIFFIER B MICHALLET M SALLES G SEBBAN C ROUBI N LOPEZ F BESSUEILLE L MAZARS P GERARD C HANANIA E RAMANATHAN R READING C JUTTNER C ATKINSON K PHILIP T
Citation: E. Archimbaud et al., SELECTED AUTOLOGOUS PERIPHERAL-BLOOD CD34-1+ LIN- HEMATOPOIETIC STEM-CELL (HSC) TRANSPLANTATION IN MULTIPLE-MYELOMA (MM)( THY), Bone marrow transplantation, 21, 1998, pp. 52-52
MULTICENTER RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY ON EFFICACY OF GM-CSF FOR COLLECTION OF PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) IN MULTIPLE-MYELOMA (MM) PATIENTS
Authors: MARIT G TO LB FLESCH M MALOISEL F BOIRON JM JUTTNER C REIFFERS J
Citation: G. Marit et al., MULTICENTER RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY ON EFFICACY OF GM-CSF FOR COLLECTION OF PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) IN MULTIPLE-MYELOMA (MM) PATIENTS, Bone marrow transplantation, 21, 1998, pp. 694-694
COLLECTION, TUMOR CONTAMINATION, AND ENGRAFTMENT KINETICS OF HIGHLY PURIFIED HEMATOPOIETIC PROGENITOR CELLS TO SUPPORT HIGH-DOSE THERAPY INMULTIPLE-MYELOMA
Authors: TRICOT G GAZITT Y LEEMHUIS T JAGANNATH S DESIKAN KR SIEGEL D FASSAS A TINDLE S NELSON J JUTTNER C TSUKAMOTO A HALLAGAN J ATKINSON K READING C HOFFMAN R BARLOGIE B
Citation: G. Tricot et al., COLLECTION, TUMOR CONTAMINATION, AND ENGRAFTMENT KINETICS OF HIGHLY PURIFIED HEMATOPOIETIC PROGENITOR CELLS TO SUPPORT HIGH-DOSE THERAPY INMULTIPLE-MYELOMA, Blood, 91(12), 1998, pp. 4489-4495
CD34(-1(+) HEMATOPOIETIC PROGENITOR CELLS ISOLATED FROM DIFFERENT PATIENTS SHOW A CONSISTENT RATIO OF CAFC AND CFU-C FREQUENCIES()THY)
Authors: HILL B TRAVIS M HANSTEEN G CULLEN S ESTRADA M WU S LEEMHUIS T JUTTNER C SCOLLAY R CHEN B YOUNG J
Citation: B. Hill et al., CD34(-1(+) HEMATOPOIETIC PROGENITOR CELLS ISOLATED FROM DIFFERENT PATIENTS SHOW A CONSISTENT RATIO OF CAFC AND CFU-C FREQUENCIES()THY), Experimental hematology, 25(8), 1997, pp. 280-280
SELECTED AUTOLOGOUS PERIPHERAL-BLOOD CD34-1+ LIN- HEMATOPOIETIC STEM-CELL (HSC) TRANSPLANTATION IN MULTIPLE-MYELOMA - A EUROPEAN STUDY( THY)
Authors: ARCHIMBAUD E PHILIP I COIFFIER B MICHALLET M SALLES G SEBBAN C ROUBI N LOPEZ F BESSUEILLE L MAZARS P GERARD C HANANIA S RAMANATHAN R READING C JUTTNER C ATKINSON K PHILIP T
Citation: E. Archimbaud et al., SELECTED AUTOLOGOUS PERIPHERAL-BLOOD CD34-1+ LIN- HEMATOPOIETIC STEM-CELL (HSC) TRANSPLANTATION IN MULTIPLE-MYELOMA - A EUROPEAN STUDY( THY), Blood, 90(10), 1997, pp. 1754-1754
RAPID HEMATOPOIETIC ENGRAFTMENT FOLLOWING TRANSPLANTATION OF PURIFIEDCD34-CELLS IN PATIENTS WITH METASTATIC BREAST-CANCER(THY1+ STEM)
Authors: NEGRIN RS TIERNEY KD STOCKERLGOLDSTEIN KE HU WW SHIZURU JA JOHNSTON LJ ATKINSON K JUTTNER C SCHNELL J HANANIA E READING C RAMANATHAN R PETERS W BLUME KG KLEIN J
Citation: Rs. Negrin et al., RAPID HEMATOPOIETIC ENGRAFTMENT FOLLOWING TRANSPLANTATION OF PURIFIEDCD34-CELLS IN PATIENTS WITH METASTATIC BREAST-CANCER(THY1+ STEM), Blood, 90(10), 1997, pp. 2635-2635
AN INCREMENTAL RESPONSE TO HIGH-DOSE THERAPY IN MULTIPLE-MYELOMA
Authors: HAWKINS T HORVATH N RAWLING C BAYLY J ANDARY C DYSON P HO J DART G JUTTNER C TO B
Citation: T. Hawkins et al., AN INCREMENTAL RESPONSE TO HIGH-DOSE THERAPY IN MULTIPLE-MYELOMA, Bone marrow transplantation, 17(6), 1996, pp. 929-935
CD34(-) PERIPHERAL-BLOOD STEM-CELLS (PBSC) TRANSPLANTATION AFTER HIGH-DOSE THERAPY FOR PATIENTS WITH MULTIPLE MYUELOMA()THY1(+)LIN()
Authors: ARCHIMBAUD E PHILIP I COIFFIER B MICHALLET M SALLES G SEBBAN C ROUBI N LOPEZ F BESSUEILLE L MAZARS P JUTTNER C ATKINSON K PHILIP T
Citation: E. Archimbaud et al., CD34(-) PERIPHERAL-BLOOD STEM-CELLS (PBSC) TRANSPLANTATION AFTER HIGH-DOSE THERAPY FOR PATIENTS WITH MULTIPLE MYUELOMA()THY1(+)LIN(), Blood, 88(10), 1996, pp. 2370-2370
AN INCREMENTAL RESPONSE TO HIGH-DOSE THERAPY IN MULTIPLE-MYELOMA
Authors: HAWKINS T HORVATH N RAWLING C BAYLY J ANDARY V DYSON P HO J DART G JUTTNER C TO L
Citation: T. Hawkins et al., AN INCREMENTAL RESPONSE TO HIGH-DOSE THERAPY IN MULTIPLE-MYELOMA, Experimental hematology, 23(8), 1995, pp. 759-759
PROPHYLACTIC GANCICLOVIR IS MORE EFFECTIVE IN HLA-IDENTICAL FAMILY MEMBER MARROW TRANSPLANT RECIPIENTS THAN IN MORE HEAVILY IMMUNE-SUPPRESSED HLA-IDENTICAL UNRELATED DONOR MARROW TRANSPLANT RECIPIENTS
Authors: ATKINSON K ARTHUR C BRADSTOCK K DALE B DOWNS K GIBSON J JOSHUA D JUTTNER C SHAW P SHERIDAN W SZER J VOWELS M
Citation: K. Atkinson et al., PROPHYLACTIC GANCICLOVIR IS MORE EFFECTIVE IN HLA-IDENTICAL FAMILY MEMBER MARROW TRANSPLANT RECIPIENTS THAN IN MORE HEAVILY IMMUNE-SUPPRESSED HLA-IDENTICAL UNRELATED DONOR MARROW TRANSPLANT RECIPIENTS, Bone marrow transplantation, 16(3), 1995, pp. 401-405
CD34- PERIPHERAL-BLOOD STEM-CELLS (PBSC) EFFECT TIMELY TRILINEAGE ENGRAFTMENT IN MULTIPLE-MYELOMA (MM)(THY+LIN)
Authors: TRICOT G GAZITT Y JAGANNATH S VESOLE D READING C JUTTNER C HOFFMAN R BARLOGIE B
Citation: G. Tricot et al., CD34- PERIPHERAL-BLOOD STEM-CELLS (PBSC) EFFECT TIMELY TRILINEAGE ENGRAFTMENT IN MULTIPLE-MYELOMA (MM)(THY+LIN), Blood, 86(10), 1995, pp. 1160-1160
MOBILIZATION OF PBPC BY PRIMING WITH STEM-CELL FACTOR (SCF) BEFORE FILGRASTIM COMPARED TO CONCURRENT ADMINISTRATION
Authors: BASSER R BEGLEY CG MANSFIELD R TO B JUTTNER C MAHER D FOX R CEBON J SZER J GRIGG A CLARK K MARTY J MENCHACA D THOMPSON B RUSSELL I COLLINS J GREEN M
Citation: R. Basser et al., MOBILIZATION OF PBPC BY PRIMING WITH STEM-CELL FACTOR (SCF) BEFORE FILGRASTIM COMPARED TO CONCURRENT ADMINISTRATION, Blood, 86(10), 1995, pp. 2734-2734
PROGNOSTIC VALUE OF IMMUNOPHENOTYPING IN ACUTE MYELOID-LEUKEMIA
Authors: BRADSTOCK K MATTHEWS J BENSON E PAGE F BISHOP J PIDCOCK M GALLO J ROSENFELD D KWAN Y TANG RLP ENNO A SELDON N GIBSON J ILAND K JOSHUA D KRONENBERG H VINCENT P YOUNG G MANOHARAN A ATKINSON K BIGGS J CONCANNON A DODDS A BENSON W GOTTLIEB D KOUTTS J LEE C TAYLOR K COBCROFT R GILL D BUNCE I DURRANT S GILLETT A HILL G ROESSER P ROONEY K KIMBER R LOWENTHAL R DALE B JUTTNER C FIRKIN B SZER J VANDERWEYDEN M WHITESIDE M COOPER I DING J JANUSZEWICZ E WOLF M FOX R GREEN M FIRKIN F LEAHY M HERRMANN R
Citation: K. Bradstock et al., PROGNOSTIC VALUE OF IMMUNOPHENOTYPING IN ACUTE MYELOID-LEUKEMIA, Blood, 84(4), 1994, pp. 1220-1225
RANDOMIZED PROSPECTIVE-STUDY DEMONSTRATING A PROLONGED EFFECT OF SCF WITH G-CSF(FILGRASTIM) ON PBPC IN UNTREATED PATIENTS - EARLY RESULTS
Authors: BEGLEY CG BASSER R MANSFIELD R MAHER D TO B JUTTNER C FOX R CEBON J GRIGG A SZER J MCGRATH K THOMSON B SHERIDAN W MENCHACA D COLLINS J RUSSELL I GREEN M
Citation: Cg. Begley et al., RANDOMIZED PROSPECTIVE-STUDY DEMONSTRATING A PROLONGED EFFECT OF SCF WITH G-CSF(FILGRASTIM) ON PBPC IN UNTREATED PATIENTS - EARLY RESULTS, Blood, 84(10), 1994, pp. 10000025-10000025
CYTOKINE-MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC)
Authors: BEGLEY CG SHERIDAN WP GRIGG A MAHER D BASSER R CEBON J JUTTNER C FOX RM
Citation: Cg. Begley et al., CYTOKINE-MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC), Journal of leukocyte biology, 1993, pp. 132-132
N-RAS MUTATION IN ACUTE MYELOID-LEUKEMIA - INCIDENCE, PROGNOSTIC-SIGNIFICANCE AND VALUE AS A MARKER OF MINIMAL RESIDUAL DISEASE
Authors: CASEY G RUDZKI Z ROBERTS M HUTCHINS C JUTTNER C
Citation: G. Casey et al., N-RAS MUTATION IN ACUTE MYELOID-LEUKEMIA - INCIDENCE, PROGNOSTIC-SIGNIFICANCE AND VALUE AS A MARKER OF MINIMAL RESIDUAL DISEASE, Pathology, 25(1), 1993, pp. 57-62
RAPID HEMATOPOIETIC RECONSTITUTION FOLLOWING 3 CYCLES OF HIGH-DOSE CHEMOTHERAPY WITH FILGRASTIM (G-CSF)-MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) AND FILGRASTIM IN PATIENTS WITH HIGH-RISK BREAST-CANCER
Authors: BASSER R TO B GREEN M SZER J BAYLY J DUGGAN G BEGLEY G DYSON P FOX R COLLINS J RUSSELL I MAHER D CEBON J MARTY J JUTTNER C DZIEM G HOFFMAN E SHERIDAN W
Citation: R. Basser et al., RAPID HEMATOPOIETIC RECONSTITUTION FOLLOWING 3 CYCLES OF HIGH-DOSE CHEMOTHERAPY WITH FILGRASTIM (G-CSF)-MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) AND FILGRASTIM IN PATIENTS WITH HIGH-RISK BREAST-CANCER, Blood, 82(10), 1993, pp. 10000233-10000233
Risultati: 1-18 |